21 Dec 2020 --- The US Federal Trade Commission (FTC) issued its first legal enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products in the US. The FTC is taking action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported claims about their ability to treat severe health conditions, including cancer, heart disease, hypertension and Alzheimer’s disease.
